Showing results (3331-3340 of 5,036) with videos related to
Sort By:
Pageof 504
Clinical Laboratory|September 25, 2012
Advantage of HbA1c assay by HPLC D-10 versus cobas integra 400 in a population carrier for HbS and HbCKahena Bouzid, Afef Bahlous, Wafa Ferjani, et al.Clinical Laboratory|September 25, 2012
Vitamin D status from dried capillary blood samplesBerthold Hocher, Hans Jürgen Grön, Claudia Schumann, et al.Clinical Laboratory|July 13, 2012
CD256 can be found in antibody-mediated renal allograft rejection tissuesHaiyan Xu, Xiaozhou He, Wei Zhao, et al.Clinical Laboratory|July 13, 2012
Comprehensive analysis of BCR/ABL variants in chronic myeloid leukemia patients using multiplex RT-PCRAyda Bennour, Ines Ouahchi, Medhaffar Moez, et al.Clinical Laboratory|July 13, 2012
CD40, CD45 CTLA-4 levels are elevated in healthy older adultsArzu Didem Yalcin, Reginald M Gorczynski, Münevver Sarigül Kahraman, et al.Clinical Laboratory|July 13, 2012
Statistical analysis of results obtained by real-time PCR for improvement of absolute quantification of target sequencesThomas Kiefer, Carsten Hirt, Frank Schüler, et al.Clinical Laboratory|July 13, 2012
Evaluation and comparison of the efficiency of immunochromatography methods for norovirus detectionAksara Thongprachum, Pattara Khamrin, Dinh Nguyen Tran, et al.Clinical Laboratory|July 13, 2012
Multicentre evaluation of a second generation point-of-care assay with an extended range for the determination of N-terminal pro-brain natriuretic peptideBo Jørgensen, Thomas Bertsch, Hans-Joachim Bröker, et al.Clinical Laboratory|July 13, 2012
The inhibition of the pemetrexed-activated MAPK pathway via sorafenib is involved in the synergistic mechanism of sorafenib subsequent potentiation of pemetrexed cytotoxicity in EGFR TKI-resistant cell linesYanwen Jiang, Chunsun Li, Yingmin Ma, et al.Clinical Laboratory|July 13, 2012
EDTA-temperature-Induced pseudohematocytopenia in a patient with multiple myelomaLixia Zhang, Shiyang Pan, Jie Zhang, et al.Pageof 504